HEPA滤网改善血糖;配备ECMO的EMS与CPR;多级瓣膜置换TAVR
HEPA Filters for Blood Sugar; ECMO-Equipped EMS & CPR; Valve-in-Valve-in-Valve TAVR
一项假对照试验显示,使用HEPA滤网改善睡眠可控制血糖;一项研究发现智能手表算法可检测高血压;荷兰研究显示配备ECMO的EMS提高心脏骤停生存率;SHOCK分类更新强调心脏源性休克的灌注、再评估和临床轨迹;其他研究涉及抗栓治疗、高血压管理、心衰预测和心脏移植后肾功能变化。
— Recent developments of interest in cardiovascular medicine
by Nicole Lou, Senior Staff Writer, MedPage Today
November 10, 2026 • 2 min read
A sham-controlled trial showed that sleeping while using high‑efficiency particulate air (HEPA) filters in the bedroom improved blood sugar control, as highlighted by NYU Langone Health.
A smartwatch artificial intelligence algorithm could detect hypertension with a sensitivity of 65.8% and specificity of 90.0%, a validation study showed. (Nature)
A Dutch trial found that equipping emergency medical services (EMS) with extracorporeal CPR technology, namely venoarterial extracorporeal membrane oxygenation (ECMO), increased survival of people with refractory out-of-hospital cardiac arrest. (New England Journal of Medicine)
The Society for Cardiovascular Angiography and Interventions SHOCK classification was updated to emphasize perfusion, serial reassessment, and clinical trajectory in describing cardiogenic shock severity. (JSCAI)
IV cangrelor (Kengreal) failed to meet noninferiority to crushed oral ticagrelor (Brilinta) for short-term clinical outcomes in a randomized trial of acute myocardial infarction complicated by cardiogenic shock. (The Lancet)
Compared with ezetimibe (Zetia), evolocumab (Repatha) was associated with a 20% lower rate of myocardial infarctions over 4 years, according to a target trial emulation study. (American Journal of Preventive Cardiology)
Early-stage data are promising for a strategy of extended aldosterone synthase inhibition, using a once-daily pill for a limited time, for remission from primary aldosteronism and its associated high blood pressure, said researchers at Queen Mary University of London.
Mineralys Therapeutics released 48-week results from the Transform-HTN open-label extension trial supporting lorundrostat for treatment of uncontrolled or resistant hypertension.
Daily voice recordings enabled the HearO voice analysis smartphone app to predict heart failure events weeks before they occurred among ambulatory heart failure patients. (JACC: Heart Failure)
In a case report, an 88-year-old woman was able to get a redo transcatheter aortic valve replacement (TAVR) after a prior valve-in-valve TAVR, which meant she got a valve within a valve within a valve. (European Heart Journal)
For people undergoing pulmonary vein isolation for persistent atrial fibrillation, adjunctive low-voltage area ablation did not reduce arrhythmia recurrence in the COAST-AF trial. (JAMA)
A single infusion of investigational factor XI inhibitors amrecibart or cenvacibart safely reduced the incidence of venous thromboembolism following peripherally inserted central catheter insertion, the ROXI-CATH phase II trial suggested. (Lancet Haematology)
More than a year after getting a heart transplant, patients initiating dapagliflozin (Farxiga) went on to have better estimated glomerular filtration rate trajectories. (Circulation)
In a real-world study of the cardiovascular safety of Bruton tyrosine kinase inhibitors used for B-cell malignant neoplasms, there was 5.9% incidence of pericardial effusion or cardiac tamponade within about 2 years of treatment initiation. (JAMA Network Open)
Massachusetts cardiologist Daniel Arnett, MD, 44, was found dead after he was seen on a bike ride. (New York Post)
来源:MedPage Today · medpagetoday.com